“With the Celesteion, we found a wide-bore system that let us scan a variety of patients comfortably, as well as being a more-than-capable planning device for both PET and CT radiation therapy,” said Dr. Mark Winkler, professor of health sciences at the University of Nevada, Las Vegas and founding partner of SDMI. “It’s become the preferred system among our patients, as well as giving us the long term outlook of more referrals with the increase in oncological offerings.”
The Celesteion is designed with the patient in mind, with features that include:
- Industry’s largest bore – Offering a feeling of openness and versatile patient positioning
- Fast and accurate diagnoses – Accurate lesion detection with time of flight technology and a 70 cm PET and CT field-of-view
- System versatility – A total cost-of-ownership solution, the Celesteion can perform diagnostic CT imaging, CT interventions, PET/CT imaging and CT radiation oncology simulation scans
- CT dose reduction – Ensuring patient safety is not a choice, Celesteion comes standard with Toshiba’s most advanced CT dose reduction technology, AIDR 3D, and conforms to the requirements of MITA’s XR-29 Smart Dose Standard
“The Celesteion was designed for our customers and their patients,” said Satrajit Misra, senior director, CT Business Unit, Toshiba. “Our partnership with SDMI highlights the commitment to serving a wide population effectively, putting patients first with a better PET/CT imaging experience.”
Toshiba will showcase the Celesteion PET/CT system at this year’s Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting in Baltimore, 6-10 June 2015 (Booth #125).
Source: Toshiba America Medical Systems, Inc.